Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cellebrite

17.57
+0.08000.46%
Pre-market: 17.56-0.0100-0.06%04:19 EDT
Volume:1.22M
Turnover:21.18M
Market Cap:3.83B
PE:-13.00
High:17.80
Open:17.40
Low:16.80
Close:17.49
Loading ...

Cellebrite management to meet with Lake Street

TIPRANKS
·
05 Mar

An Expert Method to Overcome a Turbulent Stock Market

InvestorPlace
·
01 Mar

Priority Technology Skyrockets 227% in a Year: Should You Buy it?

Zacks
·
28 Feb

Cellebrite management to meet with Craig-Hallum

TIPRANKS
·
27 Feb

Cellebrite management to meet with Needham

TIPRANKS
·
27 Feb

Cellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price Targets

Simply Wall St.
·
16 Feb

Deutsche Bank Adjusts Cellebrite DI Price Target to $27 From $24, Maintains Buy Rating

MT Newswires Live
·
14 Feb

Lake Street raises Cellebrite price target, sees pullback as buying opportunity

TIPRANKS
·
14 Feb

Cellebrite DI Price Target Maintained With a $28.00/Share by Needham

Dow Jones
·
14 Feb

Cellebrite DI Ltd (CLBT) Q4 2024 Earnings Call Highlights: Strong ARR Growth and Strategic ...

GuruFocus.com
·
14 Feb

Strategic Initiatives and Long-term Growth Drive Buy Rating for Cellebrite DI

TIPRANKS
·
14 Feb

Stock Track | Cellebrite Stock Plummets 10.87% Despite Strong Q4 Results and Upbeat Outlook

Stock Track
·
13 Feb

Cellebrite DI Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Cellebrite Q4 Adjusted Earnings Decline, Revenue Rises; Q1, 2025 Revenue Guidance Issued

MT Newswires Live
·
13 Feb

Cellebrite DI Ltd Outlook Q1 Revenue $107 Mln - $112 Mln; for FY REV Outlook $480 Mln - $490 Mln

THOMSON REUTERS
·
13 Feb

Cellebrite DI Q4 2024 Adj. EPS $0.10, Inline, Sales $109.000M Beat $107.183M Estimate

Benzinga
·
13 Feb